The Japanese pharmaceutical industry, a vital component of global innovation, faces a talent gap that resonates across multinational corporations. While Japan possesses a wealth of highly skilled professionals, a notable communication disparity impedes recruitment and career advancement, particularly in global…
HOME > LATEST
LATEST
-
REGULATORY MHLW Revises Q&A on Nitrosamine Self-Inspections, OKs Use of Interim Control Limit
June 5, 2025
-
BUSINESS Fuji Keizai Issues 2040 Market Outlook for Dermatology, Collagen Diseases and More
June 5, 2025
-
BUSINESS Takeda’s Adcetris Widens Label in Europe
June 5, 2025
-
REGULATORY MHLW Panel Clears New Drugs from MSD, Pfizer, Amicus for Approval
June 5, 2025
-
ORGANIZATION New FPMAJ Chair Pushes Category-Based Drug Pricing to Ensure Innovation, Stable Supply
June 5, 2025
-
BUSINESS Enhertu Entering New Phase of Growth with Early-Line Breast Cancer Data: CEO
June 4, 2025
-
BUSINESS Sawai Cuts FY2024 Results after Remitch Ruling, Net Profit Drops by Half
June 4, 2025
-
REGULATORY Early Honebuto Draft Contains CEA Expansion, Ramp-Up of FIH Trial Sites
June 4, 2025
-
BUSINESS Dupixent’s COPD Use Expected to Benefit Patients with Allergic Symptoms: Professor
June 3, 2025
-
ORGANIZATION New JPMA Chief Calls for Clear-Cut Evaluation of Innovation in FY2026 Reform
June 3, 2025
-
BUSINESS Kaken to Codevelop TWOCELLS’ Cell Therapy in Japan
June 3, 2025
-
BUSINESS Taiho Out-Licenses LSD1 Inhibitor to Yokohama Upstart
June 3, 2025
-
BUSINESS Nxera-Lilly Collab Hits Key Milestone, Triggers Undisclosed Payment
June 3, 2025
-
BUSINESS Enhertu Extends Survival as 2nd-Line Gastric Cancer Therapy
June 3, 2025
-
BUSINESS Kura/Kyowa Kirin’s AML Drug Accepted for US FDA Review
June 3, 2025
-
BUSINESS Fuso Sets Up 8 Billion Yen Credit Line after Remitch Ruling
June 3, 2025
-
BUSINESS Bayer Files Low-Dose MRI Contrast Agent Gadoquatrane in Japan
June 3, 2025
-
BUSINESS Servier Launches Tibsovo for IDH1-Mutated AML in Japan
June 3, 2025
-
BUSINESS Scemblix’s 1st Line Nod Will Take CML Therapy to New Stage: Professor
June 2, 2025
-
REGULATORY New Skipper of PMDA’s Review Center Wears Multiple Hats to Push Fight against Drug Loss
June 2, 2025
ページ
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…